Mono-Pal-MTO
Mono-Pal-MTO is a palm oil-based lipid produced by combining the anticancer agent mitoxantrone (MTO) with palmitoleic acid. When nanoparticles of mono-Pal-MTO and di-Pal-MTO are combined in a molar ratio of 1:1, they show effective siRNA cell delivery and enhance anticancer activity[1].
Product Specifications
CAS Number
1349197-89-2
UNSPSC
12352200
Target
Liposome
Type
Biochemical Assay Reagents
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/mono-pal-mto.html
Solubility
10 mM in DMSO
Smiles
CCCCCC/C=C\CCCCCCCC(OCCNCCNC1=C2C(C(C3=C(O)C=CC(O)=C3C2=O)=O)=C(C=C1)NCCNCCO)=O
Molecular Formula
C38H56N4O7
Molecular Weight
680.87
References & Citations
[1]Rae Sung Chang, et al. Cationic drug-derived nanoparticles for multifunctional delivery of anticancer siRNA. Biomaterials. 2011 Dec;32 (36) :9785-95.
Shipping Conditions
Room temperature
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSH032116-01 10 µg
Recombinant Human BCL-W/BCL2L2 Protein (His Tag)
Sign In for Pricing
View Details PKSH032116-02 50 µg
Recombinant Human BCL-W/BCL2L2 Protein (His Tag)
Sign In for Pricing
View Details 
BNC880956-100 1x 100 µL
UACA / Nucling (AE-5), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details